AAAAAA

   
Results: 1-9 |
Results: 9
Nuclear medicine applications for neuroendocrine tumors
Authors: Chatal, JF Le Bodic, MF Kraeber-Bodere, F Rousseau, C Resche, I
Citation: Jf. Chatal et al., Nuclear medicine applications for neuroendocrine tumors, WORLD J SUR, 24(11), 2000, pp. 1285-1289
Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement
Authors: Kraeber-Bodere, F Campion, L Rousseau, C Bourdin, S Chatal, JF Resche, I
Citation: F. Kraeber-bodere et al., Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement, EUR J NUCL, 27(10), 2000, pp. 1487-1493
Pretargeting with the Affinity Enhancement System for radioimmunotherapy
Authors: Barbet, J Kraeber-Bodere, F Vuillez, JP Gautherot, E Rouvier, R Chatal, JF
Citation: J. Barbet et al., Pretargeting with the Affinity Enhancement System for radioimmunotherapy, CANC BIO R, 14(3), 1999, pp. 153-166
Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with I-131-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody
Authors: Gautherot, E Kraeber-Bodere, F Daniel, L Fiche, M Rouvier, E Sai-Maurel, C Thedrez, P Chatal, JF Barbet, J
Citation: E. Gautherot et al., Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with I-131-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody, CLIN CANC R, 5(10), 1999, pp. 3177S-3182S
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections
Authors: Kraeber-Bodere, F Faivre-Chauvet, A Sai-Maurel, C Campion, L Fiche, M Gautherot, E Le Boterff, J Barbet, J Chatal, JF Thedrez, P
Citation: F. Kraeber-bodere et al., Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections, CLIN CANC R, 5(10), 1999, pp. 3183S-3189S
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial
Authors: Kraeber-Bodere, F Bardet, S Hoefnagel, CA Vieira, MR Vuillez, JP Murat, A Ferreira, TC Bardies, M Ferrer, L Resche, I Gautherot, E Rouvier, E Barbet, J Chatal, JF
Citation: F. Kraeber-bodere et al., Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial, CLIN CANC R, 5(10), 1999, pp. 3190S-3198S
Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial
Authors: Vuillez, JP Kraeber-Bodere, F Moro, D Bardies, M Douillard, JY Gautherot, E Rouvier, E Barbet, J Garban, F Moreau, P Chatal, JF
Citation: Jp. Vuillez et al., Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial, CLIN CANC R, 5(10), 1999, pp. 3259S-3267S
Two-step targeting and dosimetry for small cell lung cancer xenograft withanti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten
Authors: Hosono, M Hosono, MN Kraeber-Bodere, F Devys, A Thedrez, P Faivre-Chauvet, A Gautherot, E Barbet, J Chatal, JF
Citation: M. Hosono et al., Two-step targeting and dosimetry for small cell lung cancer xenograft withanti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten, J NUCL MED, 40(7), 1999, pp. 1216-1221
Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft
Authors: Kraeber-Bodere, F Faivre-Chauvet, A Sai-Maurel, C Gautherot, E Fiche, M Campion, L Le Boterff, J Barbet, J Chatal, JF Thedrez, P
Citation: F. Kraeber-bodere et al., Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft, J NUCL MED, 40(1), 1999, pp. 198-204
Risultati: 1-9 |